1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVARTIS AG - ADR
Novartis AG - ADR XNYS: NVS

Novartis AG - ADR Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the ...

Read More
127.70 1.15 (0.91%)
New 52W High in past week
906.4K
XNYS Volume

XNYS 11 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Acquisition
Novartis to acquire Tourmaline Bio for $1.4 billion to expand its cardiovascular pipeline See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
40.0 / 100
Momentum Score
Technically Neutral
59.0 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
120
1Yr Price target downside is -6%
10 analysts

15

S

3

W

0

O

3

T

SWOT Analysis

Novartis AG ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..